LRMR Latest Press Releases

-- May 14, 2026 --

Larimar Therapeutics Reports First Quarter 2026 Financial and Business Update Globe Newswire 7:00 AM

-- April 30, 2026 --

Larimar Therapeutics Publishes Cross-Species Findings Supporting Skin as a Surrogate for the Measurement of Frataxin in Tissues Clinically Relevant to Friedreich's Ataxia Globe Newswire 4:05 PM

-- March 19, 2026 --

Larimar Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results Globe Newswire 7:00 AM

-- March 4, 2026 --

Larimar Therapeutics to Participate in Upcoming Investor Conferences in March Globe Newswire 4:05 PM

-- February 25, 2026 --

Larimar Therapeutics Announces Pricing of Upsized $100 Million Underwritten Public Offering Globe Newswire 8:59 PM

Larimar Therapeutics Announces Proposed $75 Million Underwritten Public Offering Globe Newswire 4:03 PM

-- February 24, 2026 --

Biotech and Big Tech Drive the Morning Narrative Globe Newswire 10:17 AM

Larimar Therapeutics Announces FDA Breakthrough Therapy Designation for Nomlabofusp in FA and Reiterates Planned BLA Submission in June 2026 Globe Newswire 7:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software